Gain Therapeutics, Inc. (GANX) Deferred Tax Assets, Valuation Allowance USD 2020 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Gain Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2020 to 2023.
  • Gain Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $12 M, a 27.5% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $12 M +$2.6 M +27.5% Dec 31, 2023 10-K 2024-03-26
Q4 2022 $9.44 M +$4.81 M +104% Dec 31, 2022 10-K 2024-03-26
Q4 2021 $4.63 M +$3.35 M +262% Dec 31, 2021 10-K 2023-03-23
Q4 2020 $1.28 M Dec 31, 2020 10-K 2022-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.